Literature DB >> 24149717

Patterns of structural recurrence in papillary thyroid cancer.

Schelto Kruijff1, Japke F Petersen, Paul Chen, Ahmed M Aniss, Roderick J Clifton-Bligh, Stan B Sidhu, Leigh W Delbridge, Anthony J Gill, Diana Learoyd, Mark S Sywak.   

Abstract

BACKGROUND: Papillary thyroid carcinoma (PTC) is uncommonly associated with tumor-related mortality, although local recurrence can be a frequent and difficult problem. This study was conducted to clarify the pattern of structural locoregional recurrence in PTC. MATERIAL AND
METHOD: A retrospective cohort study of patients undergoing surgical intervention for PTC was undertaken. Data were collected from a comprehensive thyroid cancer database maintained within a single tertiary referral center. The primary outcome measure was cancer recurrence requiring surgical intervention. Secondary outcome measures were site of recurrence, time to recurrence, and risk factors for recurrence.
RESULTS: In the period 1980-2013, 1,183 patients with PTC were included in the study. The overall rate of structural recurrence requiring reoperative surgery was 7.9 %. The median time to reoperation was 31 months. Younger age, male gender, large primary tumor diameter, and number of positive lymph nodes at initial presentation were all significantly associated with disease recurrence. The lateral compartments (levels I, II, III, IV, V) were involved almost twice as frequently as the central compartment (level VI) (67 vs 32 %, P < 0.01). The distribution of recurrences was level I (1 %), level II (12 %), level III (18 %), level IV (18 %), level V (17 %), level VI (32 %), level VII (2 %).
CONCLUSIONS: In a center with a liberal approach to central compartment lymph node dissection for PTC, the lateral neck compartment is the most common site of structural recurrence requiring reoperative surgery.

Entities:  

Mesh:

Year:  2014        PMID: 24149717     DOI: 10.1007/s00268-013-2286-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

Review 1.  Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  F Pacini; M G Castagna; L Brilli; G Pentheroudakis
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

2.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

3.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

4.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

5.  Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis.

Authors:  Tarek Zetoune; Xavier Keutgen; Daniel Buitrago; Hasan Aldailami; Huibo Shao; Madhu Mazumdar; Thomas J Fahey; Rasa Zarnegar
Journal:  Ann Surg Oncol       Date:  2010-07-02       Impact factor: 5.344

6.  A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.

Authors:  Aleksandra Popadich; Olga Levin; James C Lee; Stephanie Smooke-Praw; Kevin Ro; Maisam Fazel; Asit Arora; Neil S Tolley; Fausto Palazzo; Diana L Learoyd; Stan Sidhu; Leigh Delbridge; Mark Sywak; Michael W Yeh
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

7.  Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.

Authors:  Mark Sywak; Lachlan Cornford; Paul Roach; Peter Stalberg; Stan Sidhu; Leigh Delbridge
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

8.  The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.

Authors:  Victor Zaydfudim; Irene D Feurer; Marie R Griffin; John E Phay
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

9.  Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma.

Authors:  Dana M Hartl; Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Martin Schlumberger
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

10.  Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma.

Authors:  J F Henry; L Gramatica; A Denizot; A Kvachenyuk; M Puccini; T Defechereux
Journal:  Langenbecks Arch Surg       Date:  1998-04       Impact factor: 3.445

View more
  17 in total

1.  Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy.

Authors:  H Vulpe; J Y Y Kwan; A McNiven; J D Brierley; R Tsang; B Chan; D P Goldstein; L W Le; A Hope; M Giuliani
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

2.  Long-term oncologic outcome of robotic versus open total thyroidectomy in PTC: a case-matched retrospective study.

Authors:  Seul Gi Lee; Jandee Lee; Min Jhi Kim; Jung Bum Choi; Tae Hyung Kim; Eun Jeong Ban; Cho Rok Lee; Sang Wook Kang; Jong Ju Jeong; Kee Hyun Nam; Young Suk Jo; Woong Youn Chung
Journal:  Surg Endosc       Date:  2015-10-30       Impact factor: 4.584

Review 3.  Differentiated thyroid cancer-personalized therapies to prevent overtreatment.

Authors:  Markus Luster; Theresia Weber; Frederik A Verburg
Journal:  Nat Rev Endocrinol       Date:  2014-07-01       Impact factor: 43.330

Review 4.  Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis.

Authors:  Kai Guo; Zhuoying Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

5.  Value of Ultrasound Combined with Immunohistochemistry Evaluation of Central Lymph Node Metastasis for the Prognosis of Papillary Thyroid Carcinoma.

Authors:  Xiaohua Yao; Ying Meng; Runsheng Guo; Guofeng Lu; Lin Jin; Yingchun Wang; Debin Yang
Journal:  Cancer Manag Res       Date:  2020-09-22       Impact factor: 3.989

6.  Sex disparities in thyroid cancer: a SEER population study.

Authors:  Peng Li; Ying Ding; Mengyuan Liu; Wenlong Wang; Xinying Li
Journal:  Gland Surg       Date:  2021-12

Review 7.  EMT, CTCs and CSCs in tumor relapse and drug-resistance.

Authors:  Abhisek Mitra; Lopa Mishra; Shulin Li
Journal:  Oncotarget       Date:  2015-05-10

8.  Analysis of Risk Factors Contributing to Recurrence of Papillary Thyroid Carcinoma in Chinese Patients Who Underwent Total Thyroidectomy.

Authors:  Wei Zhang; De Jiao; Baoguo Liu; Shanping Sun
Journal:  Med Sci Monit       Date:  2016-04-16

9.  Soft tissue invasion of papillary thyroid carcinoma.

Authors:  Jen-Der Lin; Chuen Hsueh; Tzu-Chieh Chao
Journal:  Clin Exp Metastasis       Date:  2016-05-06       Impact factor: 5.150

10.  Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis.

Authors:  Chunping Liu; Tianwen Chen; Wen Zeng; Shuntao Wang; Yiquan Xiong; Zeming Liu; Tao Huang
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.